Debt-to-equity of BIOMARIN PHARMACEUTICAL INC from 31 Mar 2011 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
BIOMARIN PHARMACEUTICAL INC quarterly Debt-to-equity in % history and change rate from 31 Mar 2011 to 30 Sep 2025.
  • BIOMARIN PHARMACEUTICAL INC Debt-to-equity for the quarter ending 30 Sep 2025 was 24%, a 28% decline year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

BIOMARIN PHARMACEUTICAL INC Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q3 2025 24% -9% -28% 30 Sep 2025
Q2 2025 24% -12% -33% 30 Jun 2025
Q1 2025 27% -11% -28% 31 Mar 2025
Q4 2024 30% -8% -22% 31 Dec 2024
Q3 2024 33% -5% -12% 30 Sep 2024
Q2 2024 36% -1% -3.8% 30 Jun 2024
Q1 2024 37% 0% -0.93% 31 Mar 2024
Q4 2023 38% 0% +0.88% 31 Dec 2023
Q3 2023 38% 0% -0.34% 30 Sep 2023
Q2 2023 38% -1% -2.9% 30 Jun 2023
Q1 2023 38% -2% -5% 31 Mar 2023
Q4 2022 38% -2% -5.9% 31 Dec 2022
Q3 2022 38% -2% -5.5% 30 Sep 2022
Q2 2022 39% -4% -10% 30 Jun 2022
Q1 2022 40% -9% -19% 31 Mar 2022
Q4 2021 40% -11% -21% 31 Dec 2021
Q3 2021 40% -13% -24% 30 Sep 2021
Q2 2021 43% -9% -17% 30 Jun 2021
Q1 2021 49% 0% +0.91% 31 Mar 2021
Q4 2020 51% +1% +2.2% 31 Dec 2020
Q3 2020 53% +4% +7.5% 30 Sep 2020
Q2 2020 52% 0% -0.59% 30 Jun 2020
Q1 2020 48% -7% -13% 31 Mar 2020
Q4 2019 49% -9% -15% 31 Dec 2019
Q3 2019 49% -13% -21% 30 Sep 2019
Q2 2019 52% -11% -17% 30 Jun 2019
Q1 2019 55% -4% -5.9% 31 Mar 2019
Q4 2018 58% +5% +9.3% 31 Dec 2018
Q3 2018 62% +14% +29% 30 Sep 2018
Q2 2018 63% +19% +42% 30 Jun 2018
Q1 2018 59% +11% +24% 31 Mar 2018
Q4 2017 54% +2% +2.9% 31 Dec 2017
Q3 2017 49% -6% -11% 30 Sep 2017
Q2 2017 44% -14% -25% 30 Jun 2017
Q1 2017 47% -10% -17% 31 Mar 2017
Q4 2016 52% -3% -5% 31 Dec 2016
Q3 2016 55% -1% -1.9% 30 Sep 2016
Q2 2016 59% +2% +3.9% 30 Jun 2016
Q1 2016 57% -1% -1.2% 31 Mar 2016
Q4 2015 55% -6% -11% 31 Dec 2015
Q3 2015 56% -7% -10% 30 Sep 2015
Q2 2015 56% +2% +3.6% 30 Jun 2015
Q1 2015 58% +11% +25% 31 Mar 2015
Q4 2014 61% +23% +62% 31 Dec 2014
Q3 2014 62% +29% +89% 30 Sep 2014
Q2 2014 54% +15% +37% 30 Jun 2014
Q1 2014 46% 0% -0.11% 31 Mar 2014
Q4 2013 38% -19% -33% 31 Dec 2013
Q3 2013 33% -27% -45% 30 Sep 2013
Q2 2013 40% -24% -38% 30 Jun 2013
Q1 2013 46% -23% -33% 31 Mar 2013
Q4 2012 57% -15% -20% 31 Dec 2012
Q3 2012 60% -13% -18% 30 Sep 2012
Q2 2012 64% -20% -24% 30 Jun 2012
Q1 2012 70% -30% -30% 31 Mar 2012
Q4 2011 71% 31 Dec 2011
Q3 2011 73% 30 Sep 2011
Q2 2011 83% 30 Jun 2011
Q1 2011 99% 31 Mar 2011
* An asterisk sign (*) next to the value indicates that the value is likely invalid.